This post was originally published on this site
At the close in Copenhagen, the OMX Copenhagen 20 added 0.15%.
The best performers of the session on the OMX Copenhagen 20 were Genmab (CSE:GMAB), which rose 1.77% or 39.0 points to trade at 2240.0 at the close. Meanwhile, Novozymes A/S B (CSE:NZYMb) added 1.67% or 6.1 points to end at 372.2 and Chr. Hansen Holding A/S (CSE:CHRH) was up 0.98% or 6.4 points to 656.8 in late trade.
The worst performers of the session were Tryg A/S (CSE:TRYG), which fell 4.84% or 9.0 points to trade at 176.9 at the close. GN Store Nord (CSE:GN) declined 2.77% or 13.3 points to end at 466.7 and Ambu A/S (CSE:AMBUb) was down 2.29% or 4.7 points to 200.4.
Rising stocks outnumbered declining ones on the Copenhagen Stock Exchange by 75 to 47 and 22 ended unchanged.
Crude oil for January delivery was up 0.89% or 0.37 to $42.02 a barrel. Elsewhere in commodities trading, Brent oil for delivery in January rose 1.30% or 0.57 to hit $44.32 a barrel, while the December Gold Futures contract fell 0.11% or 2.05 to trade at $1883.05 a troy ounce.
USD/DKK was up 0.00% to 6.2787, while EUR/DKK rose 0.06% to 7.4512.
The US Dollar Index Futures was down 0.13% at 92.282.
